Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer

Abstract

The progression of pancreatic cancer (PC) is significantly associated with tumor immune escape, which may be associated with nature killer (NK) cell dysfunction. CD226, CD96, and TIGIT, which share the ligand CD155, play important roles in the regulation of NK cell function. The present study was conducted to investigate the roles of these molecules in NK cells from PC patients. Expression of these molecules on NK cells was detected from samples of 92 pancreatic cancer patients and 40 healthy controls. The expression of CD155 was also evaluated by immunohistochemistry in 88 pancreatic cancer tissues. The percentage of CD226+ and CD96+ NK cells was significantly lower in PC patients than in the healthy controls; however, the mean fluorescence intensity of CD226 and CD96 was not significantly different between the two groups. TIGIT expression on NK cells from PC patients was similar to that in the healthy controls. Additionally, the expression of CD226 was positively correlated with CD96. Further analysis demonstrated that the decrease in the percentage of CD226+ and CD96+ NK cells was associated with tumor histological grade and lymph node metastasis. Moreover, the CD155 levels in PC tissues were significantly higher than those in adjacent tissues. Our results suggest that a lower percentage of CD226+ and CD96+ NK cells may contribute to tumor immune escape in PC patients; moreover, the use of NK cells with high CD226 and CD96 expression to treat PC cells with high CD155 expression may have potential and should be explored in the future.

PIK3R3 Promotes Metastasis of Pancreatic Cancer via ZEB1 Induced Epithelial-Mesenchymal Transition

“…Two experienced pathologists who were blinded to enrolled patients viewed the tissue sections independently. The methods for IHC assessment applied in our previous study were used here [23]. All antibodies used here were all purchased from Abcam (Cambridge, MA, USA).…”

Exploration of immunogene in colon cancer recurrence

“…In particular, 12 of the 31 identified genes have been reported in the literatures to be related to colon cancer recurrence [23][24][25][26][27][28][29][30][31][32][33][34][35][36][37], which can be regarded as validation to our prediction results for these 12 genes. For the other 19 genes identified by us, we cannot exclude the possibility that some of them are due to false positive prediction.…”

New avenues for melanoma immunotherapy: Natural Killer cells?

“…Notably, alterations in circulating NK cells frequency, phenotype and function have also been found in tumour patients and have been associated with the clinical outcome . So far, the analysis of peripheral blood NK cells in solid tumours patients showed an association between a suppressed functionally impaired NK cells phenotype and poor prognosis.…”

“…In patients affected by digestive cancers and lung adenocarcinoma, tumour progression and survival have been negatively associated with a high expression of inhibitory receptors on NK cells, particularly PD‐1 and Tim‐3, and with the downregulation of several activating receptors, the latter phenomenon correlating also with TGF‐β serum levels and tumour differentiation grade . Conversely, in these patients, survival was positively associated with NKp46 expression …”

“…80 Notably, alterations in circulating NK cells frequency, phenotype and function have also been found in tumour patients and have been associated with the clinical outcome. [81][82][83][84][85][86][87][88][89][90] So far, the analysis of peripheral blood NK cells in solid tumours patients showed an association between a suppressed functionally impaired NK cells phenotype and poor prognosis. Peripheral NK cells from metastatic melanoma patients show an exhausted phenotype, with a high expression of KIRs, low levels of NCRs and downregulation of stimulating cytokines receptors, that result in functional defects in their ability to proliferate, secrete cytokines and kill target cells.…”